Clinical trial
Zedula Special Drug Use Observational Study "Ovarian Cancer"
NCT05021562 is registered in ClinicalTrials.gov with Takeda as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Zedula Special Drug Use Observational Study "Ovarian Cancer"
- Lead sponsor
- Takeda
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 13, 2021
- Completion date
- March 31, 2026
- Enrollment
- 354 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
ovarian cancer